中国基因编辑试验死亡事件引发监管反弹担忧

本文如何被排名

Signal score

0 / 100

Composite score across the factors below. Higher = stronger signal that this story matters right now.

Newsworthiness bucket

Research

临床试验中的死亡事件引发了对一个国家生物技术产业的重大政策和安全担忧。 [lever_c_demoted from significant: ic=1 ai=0.4]

Source corroboration

Single-source cluster

Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.

Topics

policy, safety, other

Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.

AI-industry relevance

Standard

On-topic for AI-industry coverage; kept in the public index.

Story freshness

71 days old

Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

完整方法见我们的编辑标准。